GlaxoSmithKline PLC
07 October 2003
Directors' Interests
I give below details of changes in directors' interests in the Ordinary Shares
of GlaxoSmithKline plc.
1 October 2003 Abacus (GSK) Trustees Limited, as trustee of the
GlaxoSmithKline Employee Trust, ("the GSK Trust"),
transferred 3,173 Ordinary Shares in the Company on
behalf of participants in the SmithKline Beecham Mid
Term Incentive Plan.
1 October 2003 The GSK Trust sold 651 Ordinary Shares in the Company
on behalf of participants in the SmithKline Beecham
Mid Term Incentive Plan at a price of £12.513 per
share.
3 October 2003 The GSK Trust transferred 13,382 Ordinary Shares in
the Company on behalf of participants in the
SmithKline Beecham Employee Share Option Plan 1991.
The Company was advised of these transactions on 6 October 2003.
The GSK Trust is a discretionary trust of which all employees or former
employees of GlaxoSmithKline plc and its subsidiaries are potential
beneficiaries. Two of the Company's directors, Dr J-P Garnier and Mr J D Coombe
are therefore interested in the shares held in the GSK Trust from time to time
in the same way as other employees or former employees of GlaxoSmithKline plc
and its subsidiaries.
S M Bicknell
Company Secretary
7 October 2003
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.